Venetoclax shows potential for R/R hairy cell leukemia

Published Date: 13 Mar 2023

Five out of six patients with relapsed or recurrent lymphoma responded to venetoclax alone or in combination with rituximab.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

The New Canadian Guidelines for Drinking at High Risk, AUD.

2.

Key mechanism behind prostate cancer drug resistance reveals potential new treatment strategy

3.

Can Oligonucleotide Infusions Really Fix Lyme, Cancer, and Other Diseases?

4.

Three out of ten breast cancers detected between screenings, study finds

5.

Uncovered biology underlies a novel drug used to treat triple-negative breast cancer.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot